SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019244
Filing Date
2016-05-12
Accepted
2016-05-12 16:27:31
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbyl-10q_20160331.htm 10-Q 1050653
2 EX-10.3 cbyl-ex103_387.htm EX-10.3 79781
3 EX-10.4 cbyl-ex104_386.htm EX-10.4 68214
4 EX-31.1 cbyl-ex311_7.htm EX-31.1 11014
5 EX-31.2 cbyl-ex312_6.htm EX-31.2 10255
6 EX-32.1 cbyl-ex321_8.htm EX-32.1 8701
  Complete submission text file 0001564590-16-019244.txt   4547202

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbyl-20160331.xml EX-101.INS 779519
8 XBRL TAXONOMY EXTENSION SCHEMA cbyl-20160331.xsd EX-101.SCH 43643
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbyl-20160331_cal.xml EX-101.CAL 39488
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbyl-20160331_def.xml EX-101.DEF 150098
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbyl-20160331_lab.xml EX-101.LAB 330358
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbyl-20160331_pre.xml EX-101.PRE 262700
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36830 | Film No.: 161644083
SIC: 2834 Pharmaceutical Preparations